or Try an Advanced Search...

    Technical Analysis for KYMR - Kymera Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 35.21 -1.40% -0.50
    KYMR closed down 1.4 percent on Wednesday, April 24, 2024, on 60 percent of normal volume.
    Earnings due: May 2
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical KYMR trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Inside Day Range Contraction 0.00%
    20 DMA Resistance Bearish -1.40%
    Inside Day Range Contraction 2.50%
    Gapped Up Strength 2.50%
    Oversold Stochastic Weakness 2.50%
    Oversold Stochastic Weakness 3.65%
    Slingshot Bearish Bearish Swing Setup 0.26%
    Bullish Engulfing Bullish 0.26%
    Oversold Stochastic Weakness 0.26%
    Older End-of-Day Signals for KYMR ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 18 hours ago
    Fell Below 10 DMA about 20 hours ago
    10 DMA Support about 21 hours ago
    Down 2 % about 21 hours ago
    Down 1% about 21 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    KYMR Chart by TradingView
    Basic chart:

    Profile

    Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; and STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases. The company was founded in 2015 and is headquartered in Watertown, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Clinical Medicine Immunology Solid Tumors Immune System Autoimmune Disease Autoimmunity Rheumatoid Arthritis Hematologic Malignancies Atopic Dermatitis Dermatitis Hidradenitis Suppurativa

    Is KYMR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 8 Kymera Therapeutics Announces Scientific Presentations at the American Association for Cancer Research 2024 Annual Meeting
    Mar 21 Kymera Therapeutics: Advancing Into Phase 2 With Partner Sanofi - I Still Have Faith
    Mar 8 Kymera Therapeutics Presents Preclinical Data for STAT6 and TYK2 First-In-Class, Oral Degrader Immunology Programs at the American Academy of Dermatology Annual Meeting
    Mar 5 Insider Sell: CFO Bruce Jacobs Sells 3,934 Shares of Kymera Therapeutics Inc (KYMR)
    Mar 3 Analysts' Revenue Estimates For Kymera Therapeutics, Inc. (NASDAQ:KYMR) Are Surging Higher
    Feb 28 Kymera Therapeutics to Participate in Upcoming March Investor Conferences
    Feb 24 Earnings Update: Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Reported And Analysts Are Trimming Their Forecasts
    Feb 23 Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2023 Earnings Call Transcript
    Feb 23 Q4 2023 Kymera Therapeutics Inc Earnings Call
    Feb 22 Kymera Therapeutics, Inc. (KYMR) Q4 2023 Earnings Call Transcript
    See more KYMR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 45.31
    52 Week Low 9.6
    Average Volume 632,865
    200-Day Moving Average 25.54
    50-Day Moving Average 38.96
    20-Day Moving Average 36.29
    10-Day Moving Average 34.92
    Average True Range 1.88
    RSI (14) 44.13
    ADX 22.53
    +DI 16.19
    -DI 16.77
    Chandelier Exit (Long, 3 ATRs) 35.68
    Chandelier Exit (Short, 3 ATRs) 38.82
    Upper Bollinger Bands 40.14
    Lower Bollinger Band 32.43
    Percent B (%b) 0.36
    BandWidth 21.25
    MACD Line -1.16
    MACD Signal Line -1.13
    MACD Histogram -0.0314
    Fundamentals Value
    Market Cap 2.09 Billion
    Num Shares 59.4 Million
    EPS -2.86
    Price-to-Earnings (P/E) Ratio -12.31
    Price-to-Sales 46.41
    Price-to-Book 5.59
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 37.91
    Resistance 3 (R3) 38.03 37.25 37.46
    Resistance 2 (R2) 37.25 36.56 37.19 37.31
    Resistance 1 (R1) 36.23 36.14 35.84 36.11 37.16
    Pivot Point 35.45 35.45 35.26 35.39 35.45
    Support 1 (S1) 34.43 34.76 34.04 34.31 33.26
    Support 2 (S2) 33.65 34.34 33.59 33.11
    Support 3 (S3) 32.63 33.65 32.96
    Support 4 (S4) 32.51